Bridges Investment Management Inc Novartis Ag Transaction History

Bridges Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 18, 2020	SELL	$84.35 - $95.37 $796,770 - $900,865	-9,446 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $32,590 - $35,913	381 Added 4.2%	9,446 $821,000
Q1 2019 May 01, 2019	SELL	$75.32 - $86.15 $88,049 - $100,709	-1,169 Reduced 11.42%	9,065 $871,000
Q4 2018 Feb 11, 2019	BUY	$73.66 - $82.02 $402,993 - $448,731	5,471 Added 114.86%	10,234 $879,000
Q3 2018 Nov 15, 2018	BUY	$66.94 - $77.43 $318,835 - $368,799	4,763 New	4,763 $411,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $226B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Bridges Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Bridges Investment Management Inc with notifications on news.